Critical appraisal of the use of regorafenib in the management of colorectal cancer

The lack of valid clinical management options for patients affected by metastatic colorectal cancer, which has progressed after all approved standard treatments, has lead to research into new active molecules. Regorafenib is an oral small-molecule multi kinase inhibitor, binding to several intracell...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2013
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3628528/
https://ncbi.nlm.nih.gov/pubmed/23610528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S34281
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak